987 related articles for article (PubMed ID: 19535127)
21. Urothelial carcinoma of the bladder, lipid cell variant: clinicopathologic findings and LOH analysis.
Lopez-Beltran A; Amin MB; Oliveira PS; Montironi R; Algaba F; McKenney JK; de Torres I; Mazerolles C; Wang M; Cheng L
Am J Surg Pathol; 2010 Mar; 34(3):371-6. PubMed ID: 20139762
[TBL] [Abstract][Full Text] [Related]
22. Plasmacytoid urothelial carcinoma: detailed analysis of morphology with clinicopathologic correlation in 17 cases.
Nigwekar P; Tamboli P; Amin MB; Osunkoya AO; Ben-Dor D; Amin MB
Am J Surg Pathol; 2009 Mar; 33(3):417-24. PubMed ID: 19011563
[TBL] [Abstract][Full Text] [Related]
23. [Guideline on urothelial carcinoma of the bladder].
Bevers RF; Battermann JJ; Gietema JA; Hulsbergen-Van de Kaa CA; de Reijke TM; Feller N; Witjes JA; ;
Ned Tijdschr Geneeskd; 2009; 153():A956. PubMed ID: 20051162
[TBL] [Abstract][Full Text] [Related]
24. Plasmacytoid urothelial carcinoma of the bladder.
Lopez-Beltran A; Requena MJ; Montironi R; Blanca A; Cheng L
Hum Pathol; 2009 Jul; 40(7):1023-8. PubMed ID: 19297008
[TBL] [Abstract][Full Text] [Related]
25. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.
David KA; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
J Urol; 2007 Aug; 178(2):451-4. PubMed ID: 17561135
[TBL] [Abstract][Full Text] [Related]
26. Plasmacytoid urothelial carcinoma of the urinary bladder: a case report and immunohistochemical study.
Sato K; Ueda Y; Kawamura K; Aihara K; Katsuda S
Pathol Res Pract; 2009; 205(3):189-94. PubMed ID: 19041193
[TBL] [Abstract][Full Text] [Related]
27. Micropapillary transitional cell carcinoma of the urinary bladder: report of two cases.
Dhouib RS; Abbes I; Mrad K; Sassi S; Leila A; Driss M; Salah R; Romdhane KB
Pathologica; 2005 Oct; 97(5):338-40. PubMed ID: 16480033
[TBL] [Abstract][Full Text] [Related]
28. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
[TBL] [Abstract][Full Text] [Related]
29. Pseudocarcinomatous epithelial hyperplasia in the bladder unassociated with prior irradiation or chemotherapy.
Lane Z; Epstein JI
Am J Surg Pathol; 2008 Jan; 32(1):92-7. PubMed ID: 18162775
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis and treatment of bladder cancer.
Sharma S; Ksheersagar P; Sharma P
Am Fam Physician; 2009 Oct; 80(7):717-23. PubMed ID: 19817342
[TBL] [Abstract][Full Text] [Related]
31. [Urothelial carcinoma with an inverted growth pattern: a report of 4 cases].
Dzombeta T; Krajacić-Jagarcec G; Tomas D; Kraus O; Ruzić B; Kruslin B
Acta Med Croatica; 2010 Mar; 64(1):47-50. PubMed ID: 20653125
[TBL] [Abstract][Full Text] [Related]
32. Urothelial carcinoma in the prostatic urethra and prostate: current controversies.
Liedberg F; Chebil G; Månsson W
Expert Rev Anticancer Ther; 2007 Mar; 7(3):383-90. PubMed ID: 17338657
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.
Chuang AY; DeMarzo AM; Veltri RW; Sharma RB; Bieberich CJ; Epstein JI
Am J Surg Pathol; 2007 Aug; 31(8):1246-55. PubMed ID: 17667550
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of histopathological tumour growth patterns at the invasion front of T1G3 urothelial carcinoma of the bladder.
Denzinger S; Burger M; Fritsche HM; Bertz S; Hofstädter F; Wieland WF; Hartmann A; Otto W
Scand J Urol Nephrol; 2009; 43(4):282-7. PubMed ID: 19382004
[TBL] [Abstract][Full Text] [Related]
35. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
[TBL] [Abstract][Full Text] [Related]
36. Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysis.
Koga F; Yoshida S; Kawakami S; Kageyama Y; Yokoyama M; Saito K; Fujii Y; Kobayashi T; Kihara K
Urology; 2008 Aug; 72(2):384-8. PubMed ID: 18455771
[TBL] [Abstract][Full Text] [Related]
37. Urothelial carcinoma with rhabdoid features: report of 6 cases.
Parwani AV; Herawi M; Volmar K; Tsay SH; Epstein JI
Hum Pathol; 2006 Feb; 37(2):168-72. PubMed ID: 16426916
[TBL] [Abstract][Full Text] [Related]
38. Downstaging and survival benefits of neoadjuvant radiotherapy before cystectomy for patients with invasive bladder carcinoma.
Granfors T; Tomic R; Ljungberg B
Scand J Urol Nephrol; 2009; 43(4):293-9. PubMed ID: 19363744
[TBL] [Abstract][Full Text] [Related]
39. Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy.
Gupta A; Lotan Y; Bastian PJ; Palapattu GS; Karakiewicz PI; Raj GV; Schoenberg MP; Lerner SP; Sagalowsky AI; Shariat SF;
Urology; 2008 Feb; 71(2):302-7. PubMed ID: 18308108
[TBL] [Abstract][Full Text] [Related]
40. Pleomorphic giant cell carcinoma of the urinary bladder.
Lopez-Beltran A; Blanca A; Montironi R; Cheng L; Regueiro JC
Hum Pathol; 2009 Oct; 40(10):1461-6. PubMed ID: 19467692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
